Companies / Santa Cruz Biotechnology / CD3-ε (UCH-T1) Alexa Fluor® 790
Santa Cruz Biotechnology

CD3-ε (UCH-T1) Alexa Fluor® 790 | Santa Cruz Biotechnology

mouse monoclonal IgG1; CD3-ε Antibody (UCH-T1) is an IgG1 κ mouse monoclonal CD3-epsilon antibody (also designated CD3 antigen epsilon polypeptide antibody, CD3E antibody, or CD3 epsilon antibody) that detects the CD3-epsilon protein of human origin by WB, IP, IF, IHC(P) and FCM. CD3-ε Antibody (UCH-T1) is available as both the non-conjugated anti-CD3-epsilon antibody form, as well as multiple conjugated forms of anti-CD3-epsilon antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The T cell antigen receptor (TCR) recognizes foreign antigens and translates such recognition events into intracellular signals that elicit a change in the cell from a dormant to an activated state. Much of this signaling process can be attributed to a multisubunit complex of proteins that associates directly with the TCR. This complex has been designated CD3 (cluster of differentiation 3). It is composed of five invariant polypeptide chains that associate to form three dimers: a heterodimer of gamma and epsilon chains (CD3-γ and CD3-ε), a heterodimer of delta and epsilon chains (CD3-δ and CD3-ε) and a homodimer of two zeta chains (CD3-ζ) or a heterodimer of zeta and eta chains (CD3-ζ and CD3-η). CD3-ζ and CD3-η are encoded by the same gene, but differ in their carboxyl-terminal ends due to an alternative splicing event. CD3-γ, CD3-ε and CD3-δ each contain a single copy of a conserved immunoreceptor tyrosine-based activation motif (ITAM). In contrast, CD3-ζ contains three consecutive copies of the same motif. Phosphorylated ITAMs act as docking sites for protein kinases such as ZAP-70 and Syk and are also capable of regulating their kinase activity. The crystal structure of the ZAP-70 SH2 domains bound to CD3-ζ ITAMs has been solved.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.